Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mauro Pierluigi is active.

Publication


Featured researches published by Mauro Pierluigi.


Journal of Medical Genetics | 2001

Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation.

P Cerruti Mainardi; C. Perfumo; A. Calì; G Coucourde; Guido Pastore; Simona Cavani; Federico Zara; Joan Overhauser; Mauro Pierluigi; F Dagna Bricarelli

The majority of deletions of the short arm of chromosome 5 are associated with cri du chat syndrome (CdCS) and patients show phenotypic and cytogenetic variability. To perform a genotype-phenotype correlation, 80 patients from the Italian CdCS Register were analysed. Molecular cytogenetic analysis showed that 62 patients (77.50%) had a 5p terminal deletion characterised by breakpoint intervals ranging from p13 (D5S763) to p15.2 (D5S18). Seven patients (8.75%) had a 5p interstitial deletion, four (5%) a de novo translocation, and three (3.75%) a familial translocation. Of the remaining four patients, three (3.75%) had de novo 5p anomalies involving two rearranged cell lines and one (1.25%) had a 5p deletion originating from a paternal inversion. The origin of the deleted chromosome 5 was paternal in 55 out of 61 patients (90.2%). Genotype-phenotype correlation in 62 patients with terminal deletions highlighted a progressive severity of clinical manifestation and psychomotor retardation related to the size of the deletion. The analysis of seven patients with interstitial deletions and one with a small terminal deletion confirmed the existence of two critical regions, one for dysmorphism and mental retardation in p15.2 and the other for the cat cry in p15.3. Results from one patient permitted the cat cry region to be distally narrowed from D5S13 to D5S731. Furthermore, this study lends support to the hypothesis of a separate region in p15.3 for the speech delay.


American Journal of Medical Genetics Part A | 2005

Mutation analysis of the NSD1 gene in a group of 59 patients with congenital overgrowth

Massimiliano Cecconi; F. Forzano; Donatella Milani; Simona Cavani; Chiara Baldo; Angelo Selicorni; Chiara Pantaleoni; Margherita Silengo; Giovanni Battista Ferrero; Gioacchino Scarano; M. Della Monica; Rita Fischetto; Paola Grammatico; Silvia Majore; Giuseppe Zampino; Luigi Memo; E. Lucci Cordisco; G. Neri; Mauro Pierluigi; F. Dagna Bricarelli; Marina Grasso; Francesca Faravelli

Sotos syndrome is characterized by pre‐ and post‐natal overgrowth, typical craniofacial features, advanced bone age, and developmental delay. Some degree of phenotypic overlap exists with other overgrowth syndromes, in particular with Weaver syndrome. Sotos syndrome is caused by haploinsufficiency of the NSD1 (nuclear receptor SET domain containing gene 1) gene. Microdeletions involving the gene are the major cause of the syndrome in Japanese patients, whereas intragenic mutations are more frequent in nonJapanese patients. NSD1 aberrations have also been described in some patients diagnosed as Weaver syndrome. Some authors have suggested a certain degree of genotype–phenotype correlation, with a milder degree of overgrowth, a more severe mental retardation, and a higher frequency of congenital anomalies in microdeleted patients. Data on larger series are needed to confirm this suggestion. We report here on microdeletion and mutation analysis of NSD1 in 59 patients with congenital overgrowth. Fourteen novel mutations, two previously described and one microdeletion were identified. All patients with a NSD1 mutation had been clinically classified as “classical Sotos,” although their phenotype analysis demonstrated that some major criteria, such as overgrowth and macrocephaly, could be absent. All patients with confirmed mutations shared the typical Sotos facial gestalt. A high frequency of congenital heart defects was present in patients with intragenic mutations, supporting the relevance of the NSD1 gene in the pathogenesis of this particular defect.


Prenatal Diagnosis | 2009

De novo balanced chromosome rearrangements in prenatal diagnosis

Daniela Giardino; Cecilia Corti; Lucia Ballarati; Daniela Colombo; Elena Sala; Nicoletta Villa; Giuseppe Piombo; Mauro Pierluigi; Francesca Faravelli; Silvana Guerneri; Domenico Coviello; Faustina Lalatta; Ugo Cavallari; Daniela Bellotti; Sergio Barlati; Gianfranco Croci; Fabrizia Franchi; Elisa Savin; Gianfranco Nocera; Francesco Paolo Amico; Paola Granata; Rosario Casalone; Lucia Nutini; Ermanna Lisi; Francesca Torricelli; Ursula Giussani; Barbara Facchinetti; Ginevra Guanti; Marilena C. Di Giacomo; Francesco Paolo Susca

We surveyed the datasheets of 29 laboratories concerning prenatal diagnosis of de novo apparently balanced chromosome rearrangements to assess the involvement of specific chromosomes, the breakpoints distribution and the impact on the pregnancy outcome.


Epilepsia | 2006

6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: A report of five cases

Maurizio Elia; Pasquale Striano; Marco Fichera; Roberto Gaggero; Lucia Castiglia; Ornella Galesi; Michela Malacarne; Mauro Pierluigi; Carmelo Amato; Sebastiano A. Musumeci; Corrado Romano; Silvia Majore; Paola Grammatico; Federico Zara; Salvatore Striano; Francesca Faravelli

Summary:  Purpose: Mental retardation, facial dysmorphisms, and neurologic and brain abnormalities are features of 6q terminal deletions. Epilepsy is frequently associated with this chromosome abnormality, but electroclinical findings are not well delineated. We report five unrelated patients with 6q terminal deletions and a peculiar clinical, EEG, and neuroradiologic picture of epilepsy, mental retardation, and colpocephaly.


American Journal of Medical Genetics Part A | 2006

Clinical phenotype and molecular characterization of 6q terminal deletion syndrome: Five new cases

Pasquale Striano; Michela Malacarne; Simona Cavani; Mauro Pierluigi; Rosanna Rinaldi; Maria Luigia Cavaliere; Maria Michela Rinaldi; Carmelilia De Bernardo; Antonietta Coppola; Maria Pintaudi; Roberto Gaggero; Paola Grammatico; Salvatore Striano; Bruno Dallapiccola; Federico Zara; Francesca Faravelli

Mental retardation, facial dysmorphisms, seizures, and brain abnormalities are features of 6q terminal deletions. We have ascertained five patients with 6q subtelomere deletions (four de novo, one as a result of an unbalanced translocation) and determined the size of the deletion ranging from 3 to 13 Mb. Our patients showed a recognizable phenotype including mental retardation, characteristic facial appearance, and a distinctive clinico‐neuroradiological picture. Focal epilepsy with consistent electroencephalographic features and with certain brain anomalies on neuroimaging studies should suggest 6q terminal deletion. The awareness of the distinctive clinical picture will help in the diagnosis of this chromosomal abnormality.


British Journal of Haematology | 1998

Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q

Simona Cavani; C. Perfumo; Alessandra Argusti; Mauro Pierluigi; Lucia Perroni; Kjeld Schmiegelow; Michael B. Petersen; Finbarr E. Cotter; Paolo Strigini; Franca Dagna-Bricarelli; Dean Nizetic

Down syndrome (DS) children have a 10–20‐fold increased risk of developing ALL or AML compared to non‐DS children. An increased disomic homozygosity of the polymorphic DNA markers in the pericentromeric region of chromosome 21q (21q11) has repeatedly been found in DS patients with ANLL‐M7 and DS‐specific transient abnormal myelopoiesis (TAM), compared to the majority of DS subjects without leukaemia. Analysis of cytogenetic heteromorphisms and 26 polymorphic DNA markers from chromosome 21q showed an increased number of pericentromeric crossovers between the non‐disjoined chromosomes in DS‐ANLL cases (3/11), compared to DS‐ALL (0/9) and DS‐non‐leukaemic cases (0/12). These findings are compatible with the model of disomic homozygosity of the predisposing allele of a putative pericentromeric gene, as an explanation for the high prevalence of ANLL in DS.


Human Genetics | 1989

Isochromosome not translocation in trisomy 21q21q

Marina Grasso; M.L. Giovannucci Uzielli; Mauro Pierluigi; F. Tavellini; Lucia Perroni; F. Dagna Bricarelli

SummaryAfter primary trisomy, “de novo” 21q21q trisomy is the most frequent chromosomal aberration responsible for Down syndrome. This rearrangement is more commonly referred to as a Robertsonian translocation or centric fusion product than as an isochromosome, e.g., t(21q;21q) instead of i(21q); however, in practice, it has not so far proved possible to distinguish between these alternatives. The aim of this work was to establish which of the two alternatives is acceptable.


American Journal of Medical Genetics Part A | 2011

The first case of myoclonic epilepsy in a child with a de novo 22q11.2 microduplication

Maria Piccione; Davide Vecchio; Simona Cavani; Michela Malacarne; Mauro Pierluigi; Giovanni Corsello

Chromosome 22, particularly the q11.2 sub‐band, has long been recognized as responsible for multiple congenital anomaly disorders. In particular, its susceptibility to subtle microdeletions or, more rarely, microduplications has been attributed to the presence of several low‐copy repeats spanning the region as mediators of nonallelic homologous recombination that result in 22q11.2 rearrangements. While recent data suggest that the frequency of 22q11.2 microduplications could be approximately half of all deletions, now only 50 unrelated cases have been reported thus far. However, it is reasonable to suppose that microduplications of 22q11.2 may be largely undetected as a result of a less‐distinct, unpredictable, and/or milder phenotype ranging from normal to mild learning difficulties with/without other multiple defects. We report on the first case of myoclonic epilepsy in a 10‐year‐old boy carrying a de novo 22q11.2 microduplication. Emphasizing that this rare association could be one of the many unrecognized aspects underlying this new emerging syndrome and once again its clinical heterogeneity, we suggest further investigation of the function of the RAB36 gene and propose that in the screening of individuals with developmental delay, minor behavioral problems mild dysmorphology and seizures, investigation of 22q11.2 microduplications should be considered.


Genetics in Medicine | 2005

Cytogenetic and molecular evaluation of 241 small supernumerary marker chromosomes: cooperative study of 19 Italian laboratories

Leda Dalprà; Daniela Giardino; Palma Finelli; Cecilia Corti; Chiara Valtorta; Silvana Guerneri; Patrizia Ilardi; Renato Fortuna; Domenico Coviello; Gianfranco Nocera; Francesco Paolo Amico; Emanuela Martinoli; Elena Sala; Nicoletta Villa; Francesca Crosti; Francamaria Chiodo; Ludovica Verdun di Cantogno; Elisa Savin; Gianfranco Croci; Fabrizia Franchi; Giovanna Venti; Emilio Donti; Valeria Migliori; Antonella Pettinari; Stefania Bonifacio; Claudia Centrone; Francesca Torricelli; Simona Rossi; Paolo Simi; Paola Granata

Purpose: We evaluated the experiences of 19 Italian laboratories concerning 241 small supernumerary marker chromosomes (sSMCs) with the aim of answering questions arising from their origin from any chromosome, their variable size and genetic content, and their impact on the carriers phenotype.Methods: Conventional protocols were used to set up the cultures and chromosome preparations. Both commercial and homemade probes were used for the fluorescent in situ hybridization analyses.Results: A total of 113 of the 241 sSMCs were detected antenatally, and 128 were detected postnatally. There were 52 inherited and 172 de novo cases. Abnormal phenotype was present in 137 cases (57%), 38 of which were antenatally diagnosed. A mosaic condition was observed in 87 cases (36%). In terms of morphology, monocentric and dicentric bisatellited marker chromosomes were the most common, followed by monocentric rings and short-arm isochromosomes. The chromosomes generating the sSMCs were acrocentric in 132 cases (69%) and non-acrocentric chromosomes in 60 cases (31%); a neocentromere was hypothesized in three cases involving chromosomes 6, 8, and 15.Conclusion: The presented and published data still do not allow any definite conclusions to be drawn concerning karyotype–phenotype correlations. Only concerted efforts to characterize molecularly the sSMCs associated or not with a clinical phenotype can yield results suitable for addressing karyotype–phenotype correlations in support of genetic counseling.


Epilepsia | 2002

Mild Generalized Epilepsy and Developmental Disorder Associated with Large Inv Dup(15)

Rosanna Chifari; Renzo Guerrini; Mauro Pierluigi; Simona Cavani; V. Sgro; Maurizio Elia; R. Canger; Maria Paola Canevini

Summary:  Purpose: Several studies attempted to clarify the genotype–phenotype correlations in patients with inverted duplication of chromosome 15 [inv dup(15)], which is usually characterized by severe mental retardation and epilepsy in individuals with large duplications including the Prader–Willi/Angelman region. We report two patients with inv dup(15) who, in spite of a large duplication, had a mild phenotype including adult‐onset epilepsy. This report may help to define the milder spectrum of the syndrome.

Collaboration


Dive into the Mauro Pierluigi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francesca Faravelli

Great Ormond Street Hospital for Children NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lucia Perroni

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge